Status:

COMPLETED

Heading in Football: Impact on Neural Blood Biomarkers

Lead Sponsor:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborating Sponsors:

Koninklijke Nederlandse VoetbalBond (KNVB)

Conditions:

Head Injury, Minor

Concussion, Mild

Eligibility:

MALE

18+ years

Brief Summary

The goal of this observational study is to evaluate the safety of heading in football. We will study the release of biomarkers in blood that reflect microscopic neural damage. The main questions this ...

Detailed Description

The objective of this prospective observational study is to determine the potential impact of ball heading in football on brain integrity as assessed by blood biomarkers for neural damage in a real-wo...

Eligibility Criteria

Inclusion

  • Member of the KNVB;
  • 18 years or older;
  • Male
  • Self-reported fitness to play 70-90 minutes (absence of injury).

Exclusion

  • Sustained a head injury in the last year;
  • History or current neurological condition;
  • Regular participation in other contact sports (e.g. rugby, American football, ice hockey, fighting sports);
  • (Former) military personnel with a history of fighting/blast exposure

Key Trial Info

Start Date :

August 13 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 17 2024

Estimated Enrollment :

335 Patients enrolled

Trial Details

Trial ID

NCT06147596

Start Date

August 13 2024

End Date

December 17 2024

Last Update

May 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Amsterdam UMC

Amsterdam, Netherlands, 1105AZ

Heading in Football: Impact on Neural Blood Biomarkers | DecenTrialz